Fig. 4
From: CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancers
Relation of CEP55 expression with disease-free interval and progression-free interval of cancer patients. Panels A and B: CEP55 expression was related to the prognosis of patients in most cancers. Panels B and D: CEP55 expression was related to the prognosis of patients in some cancers; the red curve represents the high-CEP55 expression group, while the blue curve represents the low-CEP55 expression group. *p < 0.05